All Stories

  1. Mediterranean diet and health outcomes in idiopathic inflammatory myopathies

    Article • Rheumatology, August 2026, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  2. Myokines in Polycystic Ovary Syndrome as Exploratory Markers of Metabolic Dysregulation: A Cross-Sectional Case-Control Study

    Article • SN Comprehensive Clinical Medicine, June 2026, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  3. The future of magnetic resonance imaging: our experience and literature review of actual tendencies

    Article • Pharmacia, June 2026, Pensoft Publishers

    Dr Tsvetelina V Velikova

  4. Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohort

    Article • Rheumatology International, May 2026, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  5. Evaluating the consistency of ANA results: A cross-method study of three immunodiagnostic techniques

    Article • Pharmacia, April 2026, Pensoft Publishers

    Dr Tsvetelina V Velikova

  6. Air Pollution as a Driver of Recurrent Upper-Airway Infections and Comorbid Health Issues

    Article • Sinusitis, April 2026, MDPI AG

    Dr Tsvetelina V Velikova

  7. UNDER-RECOGNITION OF MENOPAUSE-RELATED SYMPTOMS AND TREATMENT PATTERNS: A CROSS-SECTIONAL SURVEY OF WOMEN

    Article • Anti-Aging Eastern Europe, March 2026, Medical Center "Edem Medical" LLC

    Dr Tsvetelina V Velikova

  8. Role of IL-13 in allergic rhinitis inflammation: Preliminary results

    Article • Pharmacia, March 2026, Pensoft Publishers

    Dr Tsvetelina V Velikova

  9. The dual role of inflammation and tertiary lymphoid structures in tumor progression and immunity: a literature review and our experience

    Article • Pharmacia, March 2026, Pensoft Publishers

    Dr Tsvetelina V Velikova

  10. Assessing Intestinal Inflammation: A Comparison of Immunochromatographic Tests and ELISA for Fecal Calprotectin Detection

    Article • Gastroenterology Insights, March 2026, MDPI AG

    Dr Tsvetelina V Velikova

  11. Time series analysis and modelling of MIS-C cases: can we predict MIS-C cases by new cases in the 0–18 age group?

    Article • Pharmacia, January 2026, Pensoft Publishers

    Dr Tsvetelina V Velikova

  12. Markers for the Severity of Multisystem Inflammatory Syndrome in Children: A Multivariate Analysis

    Article • International Journal of Pediatrics, January 2026, Wiley

    Dr Tsvetelina V Velikova

  13. Neurological manifestations of MIS-C: a single-center experience and case-based literature review

    Article • Pharmacia, November 2025, Pensoft Publishers

    Dr Tsvetelina V Velikova

  14. CAR T-cell therapy in systemic lupus erythematosus: a scoping review

    Article • Pharmacia, November 2025, Pensoft Publishers

    Dr Tsvetelina V Velikova

  15. Gene expression of cytokines IL-17 and IL-33 in plasma and nasal lavage fluid of patients with allergic rhinitis and bronchial asthma

    Article • Pharmacia, November 2025, Pensoft Publishers

    Dr Tsvetelina V Velikova

  16. Three years post-pandemic of SARS-CoV-2: Insights from a Bulgarian online survey

    Article • Pharmacia, November 2025, Pensoft Publishers

    Dr Tsvetelina V Velikova , Emilia Krassimirova Naseva

  17. Emerging Therapeutic and Inflammation Biomarkers: The Role of Meteorin-Like (Metrnl) and Follistatin-Like 1 (FSTL1) in Inflammatory Diseases

    Article • International Journal of Molecular Sciences, October 2025, MDPI AG

    Dr Tsvetelina V Velikova

  18. The challenges in symptomatic therapy of post-COVID-19: a Bulgarian cohort study

    Article • Pharmacia, September 2025, Pensoft Publishers

    Dr Tsvetelina V Velikova

  19. Cardiometabolic improvements, sleep apnea reduction, and biomarker modulation under dual GLP-1RA and SGLT2i therapy: a prospective study

    Article • Pharmacia, September 2025, Pensoft Publishers

    Dr Tsvetelina V Velikova

  20. Editorial: Bridging science and innovation advances in diagnosis, therapy, and translational medicine

    Article • Pharmacia, September 2025, Pensoft Publishers

    Dr Tsvetelina V Velikova

  21. Integrated Evaluation of CPAP Therapy in Type 2 Diabetic Patients with Sleep Apnea: Quality of Life and Effects on Metabolic Function and Inflammation in Outpatient Care

    Article • Diabetology, September 2025, MDPI AG

    Dr Tsvetelina V Velikova , Emilia Krassimirova Naseva

  22. Immunological Strategies for Enhancing Viral Neutralization and Protection in Antibody-Guided Vaccine Design

    Article • Biologics, July 2025, MDPI AG

    Dr Tsvetelina V Velikova

  23. Rare sporadic endolymphatic sac tumors: A case report and literature review

    Article • Surgery Case Reports, July 2025, Elsevier

    Dr Tsvetelina V Velikova

  24. Effects of SGLT2 Inhibitors on Sleep Apnea Parameters and Cheyne–Stokes Respiration in Patients with Acute Decompensated Heart Failure: A Prospective Cohort Study

    Article • Biomedicines, June 2025, MDPI AG

    Dr Tsvetelina V Velikova

  25. Targeted Treatment Approaches for Gastrointestinal Metastases of Malignant Melanoma: Clinical Insights and Overcoming Drug Resistance

    Article • Targets, June 2025, MDPI AG

    Dr Tsvetelina V Velikova

  26. New Players in Metabolic Syndrome

    Article • Metabolites, June 2025, MDPI AG

    Dr Tsvetelina V Velikova

  27. MicroRNAs in Systemic Sclerosis: Involvement in Disease Pathogenesis and Potential Use as Diagnostic Biomarkers and Therapeutic Targets

    Article • Biomedicines, May 2025, MDPI AG

    Dr Tsvetelina V Velikova

  28. Potential for Misinterpretation in the Laboratory Diagnosis of Clostridioides difficile Infections

    Article • Diagnostics, May 2025, MDPI AG

    Dr Tsvetelina V Velikova

  29. Quality of Life and Mental Health in Patients with Exacerbated Heart Failure: The Role of Obstructive and Central Sleep Apnea Phenotypes

    Article • Journal of Mind and Medical Sciences, April 2025, MDPI AG

    Dr Tsvetelina V Velikova

  30. Regulatory T cell-based therapies for type 1 diabetes: a narrative review

    Article • Metabolism and Target Organ Damage, April 2025, OAE Publishing

    Dr Tsvetelina V Velikova

  31. Integrating Primary Care and Specialized Therapies in Rheumatoid Arthritis: Optimizing Recognition, Management, and Referral Practices

    Article • Rheumato, March 2025, MDPI AG

    Dr Tsvetelina V Velikova

  32. Nasopharyngeal Colonization and Antimicrobial Susceptibility of Bacterial Isolates in Children and Young Adults with Acute, Protracted, and Chronic Cough: A Cross-Sectional Bulgarian Study

    Article • Acta Microbiologica Hellenica, March 2025, MDPI AG

    Dr Tsvetelina V Velikova

  33. GENETIC ASPECTS OF AGING AND FERTILITY

    Article • Anti-Aging Eastern Europe, December 2024, Medical Center "Edem Medical" LLC

    Dr Tsvetelina V Velikova

  34. Preclinical and Clinical Data on Current Therapeutic Options for Micro- and Macrovascular Abnormalities in Systemic Sclerosis

    Article • Sclerosis, October 2024, MDPI AG

    Dr Tsvetelina V Velikova

  35. Targeting CD3-CD16+CD56+ NK Cells and NK Cell Activity by Intralipid in the Management of Reproductive Failure

    Article • Targets, October 2024, MDPI AG

    Dr Tsvetelina V Velikova

  36. Serum podocalyxin levels in patients with obesity and carbohydrates disorders

    Article • Pharmacia, October 2024, Pensoft Publishers

    Dr Tsvetelina V Velikova

  37. Complicated Pneumonia in a Child: Hydropneumothorax Associated with MIS-C and GAS Superinfection

    Article • Pediatric Reports, September 2024, MDPI AG

    Dr Tsvetelina V Velikova

  38. Management of Coronary Artery Diseases in Systemic Vasculitides: Complications and Strategies

    Article • Medicina, September 2024, MDPI AG

    Dr Tsvetelina V Velikova

  39. Biomacromolecules as Immunomodulators: Utilizing Nature’s Tools for Immune Regulation

    Article • Macromol—A Journal of Macromolecular Research, September 2024, MDPI AG

    Dr Tsvetelina V Velikova

  40. Lung Involvement in Systemic Sclerosis—From Pathogenesis to Prediction

    Article • Sclerosis, August 2024, MDPI AG

    Dr Tsvetelina V Velikova

  41. Nutritional Management and Physical Activity in the Treatment of Sarcopenic Obesity: A Review of the Literature

    Article • Nutrients, August 2024, MDPI AG

    Dr Tsvetelina V Velikova

  42. Mucosal Immunity and Trained Innate Immunity of the Gut

    Article • Gastroenterology Insights, August 2024, MDPI AG

    Dr Tsvetelina V Velikova

  43. Dietary Supplements as Concentrated Sources of Nutrients with a Nutritional or Physiological Effect for Children with Inflammatory Bowel Disease

    Article • Gastroenterology Insights, July 2024, MDPI AG

    Dr Tsvetelina V Velikova

  44. Primary Signet-Ring-Cell Carcinoma in the Colorectum: A Case-Based Literature Review

    Article • Gastroenterology Insights, July 2024, MDPI AG

    Dr Tsvetelina V Velikova

  45. Biomacromolecules As Immunomodulators: Utilizing Nature’s Tools for Immune Regulation

    Article • July 2024, MDPI AG

    Dr Tsvetelina V Velikova

  46. Exploring the Role of the Microbiome in Rheumatoid Arthritis—A Critical Review

    Article • Microorganisms, July 2024, MDPI AG

    Dr Tsvetelina V Velikova

  47. Exploring Gut–Brain Interaction Disorders: Mechanisms and Translational Therapies Crossing Neurology to Gastroenterology

    Article • Gastroenterology Insights, July 2024, MDPI AG

    Dr Tsvetelina V Velikova

  48. In the Pursuit of Precision: Novel Target Therapies Revolutionizing SLE Care

    Article • Rheumato, June 2024, MDPI AG

    Dr Tsvetelina V Velikova

  49. Cytokine Signatures in Inflamed Mucosa of IBD Patients: State-of-the-Art

    Article • Gastroenterology Insights, June 2024, MDPI AG

    Dr Tsvetelina V Velikova

  50. p16 Expression in Multinucleated Stromal Cells of Fibroepithelial Polyps of the Anus (FEPA): A Comprehensive Review and Our Experience

    Article • Gastroenterology Insights, May 2024, MDPI AG

    Dr Tsvetelina V Velikova

  51. Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group

    Article • International Journal of Rheumatic Diseases, May 2024, Wiley

    Dr Tsvetelina V Velikova

  52. Expanding the role of CAR T‐cell therapy: From B‐cell hematological malignancies to autoimmune rheumatic diseases

    Article • International Journal of Rheumatic Diseases, May 2024, Wiley

    Dr Tsvetelina V Velikova

  53. Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges

    Article • International Journal of Rheumatic Diseases, May 2024, Wiley

    Dr Tsvetelina V Velikova

  54. Autoantibodies related to ataxia and other central nervous system manifestations of gluten enteropathy

    Article • World Journal of Clinical Cases, April 2024, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  55. New Biomarkers for Systemic Necrotizing Vasculitides

    Article • Journal of Clinical Medicine, April 2024, MDPI AG

    Dr Tsvetelina V Velikova

  56. Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies

    Article • Rheumatology International, April 2024, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  57. Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study

    Article • Rheumatology International, March 2024, Springer Science + Business Media

    Cristiana Sieiro Santos, Dr Tsvetelina V Velikova

  58. Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study

    Article • Rheumatology, March 2024, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  59. Aortic Elasticity and Cardiovascular Risk Stratification: A Narrative Review on the Current Understanding

    Article • Journal of Vascular Diseases, March 2024, MDPI AG

    Dr Tsvetelina V Velikova

  60. Eosinophilic Cationic Protein and Immunoglobulin E: Unraveling Biomarkers in Chronic Pediatric Cough

    Article • Sinusitis, February 2024, MDPI AG

    Dr Tsvetelina V Velikova

  61. Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development

    Article • Antibodies, February 2024, MDPI AG

    Dr Tsvetelina V Velikova

  62. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis

    Article • World Journal of Clinical Cases, February 2024, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  63. Chemerin in Obese Patients with Nonalcoholic Fatty Liver Disease with or without Prediabetes

    Article • Proceedings of the Bulgarian Academy of Sciences, January 2024, Prof. Marin Drinov Academic Publishing House

    Dr Tsvetelina V Velikova

  64. Meteorin-like Protein and Zonulin in Polycystic Ovary Syndrome: Exploring Associations with Obesity, Metabolic Parameters, and Inflammation

    Article • Biomedicines, January 2024, MDPI AG

    Dr Tsvetelina V Velikova

  65. Navigating the Cytokine Seas: Targeting Cytokine Signaling Pathways in Cancer Therapy

    Article • International Journal of Molecular Sciences, January 2024, MDPI AG

    Dr Tsvetelina V Velikova

  66. Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey

    Article • Rheumatology Advances in Practice, January 2024, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  67. Cardiovascular Manifestations of Multisystem Inflammatory Syndrome in Children: A Single-Center Bulgarian Study

    Article • Medicina, December 2023, MDPI AG

    Dr Tsvetelina V Velikova

  68. Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis

    Article • Antibodies, December 2023, MDPI AG

    Dr Tsvetelina V Velikova

  69. Interleukin-6: Unravelling its role in sarcopenia pathogenesis and exploring therapeutic avenues

    Article • Pharmacia, December 2023, Pensoft Publishers

    Dr Tsvetelina V Velikova

  70. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group

    Article • Rheumatology International, December 2023, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  71. Navigating the Challenges of Gluten Enteropathy and Infertility: The Role of Celiac-Related Antibodies and Dietary Changes

    Article • Antibodies, December 2023, MDPI AG

    Dr Tsvetelina V Velikova

  72. Relationship of serum Fetuin-A with metabolic and vascular parameters in patients with prediabetes and type 2 diabetes mellitus

    Article • Pharmacia, December 2023, Pensoft Publishers

    Dr Tsvetelina V Velikova

  73. Flares of autoimmune rheumatic disease following COVID‐19 infection: Observations from the COVAD study

    Article • International Journal of Rheumatic Diseases, November 2023, Wiley

    Dr Tsvetelina V Velikova

  74. Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases

    Article • Gastroenterology Insights, November 2023, MDPI AG

    Dr Tsvetelina V Velikova

  75. Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination

    Article • Biomedicines, October 2023, MDPI AG

    Dr Tsvetelina V Velikova

  76. Applications of time series analysis in epidemiology: Literature review and our experience during COVID-19 pandemic

    Article • World Journal of Clinical Cases, October 2023, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  77. SARS-CoV-2 Variant-Specific Gastrointestinal Symptoms of COVID-19: 2023 Update

    Article • Gastroenterology Insights, October 2023, MDPI AG

    Dr Tsvetelina V Velikova

  78. Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset

    Article • Modern Rheumatology, September 2023, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  79. Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art

    Article • World Journal of Clinical Oncology, September 2023, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  80. Multinucleated giant cells of bladder mucosa are modified telocytes: Diagnostic and immunohistochemistry algorithm and relation to PD-L1 expression score

    Article • World Journal of Clinical Cases, September 2023, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  81. High Concordance of CT Colonography and Colonoscopy Allows for the Distinguishing and Diagnosing of Intestinal Diseases

    Article • Life, September 2023, MDPI AG

    Dr Tsvetelina V Velikova

  82. Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study

    Article • Journal of Diabetes Investigation, September 2023, Wiley

    Dr Tsvetelina V Velikova

  83. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

    Article • Rheumatology International, September 2023, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  84. Endothelial Dysfunction and Pregnant COVID-19 Patients with Thrombophilia: A Narrative Review

    Article • Biomedicines, September 2023, MDPI AG

    Dr Tsvetelina V Velikova

  85. COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study

    Article • Rheumatology, July 2023, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova , Dr Vikas Gupta

  86. Long-term effectiveness, outcomes and complications of bariatric surgery

    Article • World Journal of Clinical Cases, July 2023, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  87. The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice

    Article • Vaccines, June 2023, MDPI AG

    Dr Tsvetelina V Velikova

  88. Clinical and Laboratory Manifestation of Gastrointestinal Involvement in MIS-C: A Single-Center Observational Study

    Article • Gastroenterology Insights, June 2023, MDPI AG

    Dr Tsvetelina V Velikova

  89. Genetic and Epigenetic Factors in Risk and Susceptibility for Childhood Asthma

    Article • Allergies, June 2023, MDPI AG

    Dr Tsvetelina V Velikova

  90. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey

    Article • Rheumatology International, June 2023, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  91. In Silico Probiogenomic Characterization of Lactobacillus delbrueckii subsp. lactis A4 Strain Isolated from an Armenian Honeybee Gut

    Article • Insects, June 2023, MDPI AG

    Dr Tsvetelina V Velikova

  92. POS0573 COMORBIDITIES, COMPLEX MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES AMONGAUTOIMMUNE RHEUMATIC DISEASES: DATA FROM THE COVAD STUDY

    Article • Annals of the Rheumatic Diseases, June 2023, Elsevier

    Dr Tsvetelina V Velikova

  93. OP0082 COVID-19 VACCINE SAFETY DURING PREGNANCY AND BREASTFEEDING IN WOMEN WITH AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY

    Article • Annals of the Rheumatic Diseases, June 2023, Elsevier

    Dr Tsvetelina V Velikova

  94. POS0558 FLARES OF AUTOIMMUNE RHEUMATIC DISEASE FOLLOWING COVID-19 INFECTION: OBSERVATIONS FROM THE COVAD STUDY

    Article • Annals of the Rheumatic Diseases, June 2023, Elsevier

    Dr Tsvetelina V Velikova

  95. POS1231 IMPAIRED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A CROSS-SECTIONAL ANALYSIS FROM AN INTERNATIONAL E-SURVEY

    Article • Annals of the Rheumatic Diseases, June 2023, Elsevier

    Dr Tsvetelina V Velikova

  96. POS1216 MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: DATA FROM A LARGE, GLOBAL E-SURVEY (COVAD STUDY)

    Article • Annals of the Rheumatic Diseases, June 2023, Elsevier

    Dr Tsvetelina V Velikova

  97. POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY

    Article • Annals of the Rheumatic Diseases, June 2023, Elsevier

    Dr Tsvetelina V Velikova

  98. POS1254 REDUCED HEALTH-RELATED QUALITY OF LIFE USING PROMIS IN PATIENTS WITH SYSTEMIC SCLEROSIS: A CROSS-SECTIONAL ANALYSIS FROM THE INTERNATIONAL COVAD-2 E-SURVEY

    Article • Annals of the Rheumatic Diseases, June 2023, Elsevier

    Dr Tsvetelina V Velikova

  99. AB1295 SAFETY AND TOLERANCE OF ANTI-SARS-CoV-2 VACCINES IN SJÖGREN'S SYNDROME: RESULTS FROM THE COVAD STUDY

    Article • Annals of the Rheumatic Diseases, June 2023, Elsevier

    Dr Tsvetelina V Velikova

  100. Editorial: Recent advances and new biomarkers in ulcerative colitis

    Article • Frontiers in Medicine, May 2023, Frontiers

    Dr Tsvetelina V Velikova

  101. AB1312 MYOSITIS PATIENTS WITHOUT AUTOIMMUNE MULTIMORBIDITY AT LOWER RISK OF DELAYED ONSET COVID-19 VACCINE ADVERSE EVENTS THAN OTHER AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY

    Article • May 2023, BMJ

    Dr Tsvetelina V Velikova

  102. Future of prostate imaging: Artificial intelligence in assessing prostatic magnetic resonance imaging

    Article • World Journal of Radiology, May 2023, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  103. Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study

    Article • Rheumatology, May 2023, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  104. Anandamide is associated with waist-to-hip ratio but not with Body Mass Index in women with polycystic ovary syndrome

    Article • Minerva Endocrinology, May 2023, Edizioni Minerva Medica

    Dr Tsvetelina V Velikova

  105. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys

    Article • Rheumatology, April 2023, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  106. EPIGENETIC ALTERATIONS IN GENE EXPRESSION IN THE AGING IMMUNE SYSTEM

    Article • Anti-Aging Eastern Europe, April 2023, Medical Center "Edem Medical" LLC

    Dr Tsvetelina V Velikova

  107. Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study

    Article • Rheumatology, April 2023, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  108. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey

    Article • Rheumatology International, March 2023, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  109. COVID-19 related liver injuries in pregnancy

    Article • World Journal of Clinical Cases, March 2023, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  110. Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys

    Article • Rheumatology, March 2023, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  111. Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Dr Tsvetelina V Velikova

  112. Retroperitoneal and abdominal bleeding in anticoagulated COVID-19 hospitalized patients: Case series and brief literature review

    Article • World Journal of Clinical Cases, March 2023, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  113. Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study

    Article • International Journal of Rheumatic Diseases, March 2023, Wiley

    Dr Tsvetelina V Velikova

  114. Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine

    Article • Antibodies, March 2023, MDPI AG

    Dr Tsvetelina V Velikova

  115. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

    Article • Rheumatology, February 2023, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova , Airenakho Emorinken

  116. Changes in Patterns of Infectivity and Mortality with SARS-CoV-2 Omicron Variant in Bulgaria

    Article • January 2023, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  117. COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease

    Article • Vaccines, December 2022, MDPI AG

    Dr Tsvetelina V Velikova

  118. Immunomodulators Containing Epicor, Colostrum, Vitamin D, Zinc, Lactobacilli and Bifidobacterium Reduce Respiratory Exacerbations in Children and Adults with Chronic Pulmonary Diseases

    Article • Sinusitis, December 2022, MDPI AG

    Dr Tsvetelina V Velikova

  119. Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study

    Article • Rheumatology, November 2022, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  120. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis

    Article • Rheumatology, October 2022, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova , Dr Vikas Gupta

  121. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Dise...

    Article • Rheumatology International, October 2022, Springer Science + Business Media

    Dr Tsvetelina V Velikova , Dr Vikas Gupta

  122. Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy

    Article • World Journal of Diabetes, September 2022, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  123. Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Bulgaria: An Internet-Based Survey

    Article • Digestive Diseases, August 2022, Karger Publishers

    Dr Tsvetelina V Velikova

  124. COVAD survey 2 long-term outcomes: unmet need and protocol

    Article • Rheumatology International, August 2022, Springer Science + Business Media

    Dr Tsvetelina V Velikova , Airenakho Emorinken

  125. COVID‐19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies

    Article • Muscle & Nerve, August 2022, Wiley

    Dr Tsvetelina V Velikova

  126. Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey

    Article • Rheumatology, August 2022, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  127. COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study

    Article • Rheumatology, June 2022, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  128. POS0201 COVID-19 SEVERITY AND VACCINE BREAKTHROUGH INFECTIONS IN IDIOPATHIC INFLAMMATORY MYOPATHIES, OTHER SYSTEMIC AUTOIMMUNE AND INFLAMMATORY DISEASES, AND HEALTHY INDIVIDUALS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY.

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Dr Tsvetelina V Velikova

  129. POS1260 COVID-19 VACCINATION-RELATED ADVERSE EVENTS AMONG AUTOIMMUNE DISEASE PATIENTS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Dr Tsvetelina V Velikova

  130. POS0899 HIGH FATIGUE SCORES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A MULTIGROUP COMPARATIVE STUDY FROM THE COVAD E-SURVEY.

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Dr Tsvetelina V Velikova

  131. POS0855 IMPAIRED PROMIS PHYSICAL FUNCTION IN IDIOPATHIC INFLAMMATORY MYOPATHY PATIENTS: RESULTS FROM THE MULTICENTER COVAD PATIENT REPORTED E-SURVEY

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Dr Tsvetelina V Velikova

  132. OP0161 TREATMENT PATTERNS OF IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM AN INTERNATIONAL COHORT OF OVER 1,400 PATIENTS

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Dr Tsvetelina V Velikova

  133. Vaccine Hesitancy in Patients with Autoimmune Diseases: Data from the Coronavirus Disease-2019 Vaccination in Autoimmune Diseases Study

    Article • Indian Journal of Rheumatology, June 2022, SAGE Publications

    Dr Tsvetelina V Velikova

  134. Nutritional Management of Thyroiditis of Hashimoto

    Article • International Journal of Molecular Sciences, May 2022, MDPI AG

    Dr Tsvetelina V Velikova

  135. Food Sensitization Impact on Asthma Attacks in Children According to Age Group

    Article • Allergies, April 2022, MDPI AG

    Dr Tsvetelina V Velikova

  136. Cellular, Antibody and Cytokine Pathways in Children with Acute SARS-CoV-2 Infection and MIS-C—Can We Match the Puzzle?

    Article • Antibodies, April 2022, MDPI AG

    Dr Tsvetelina V Velikova

  137. Specific Immunoglobulin E and G to Common Food Antigens and Increased Serum Zonulin in IBS Patients: A Single-Center Bulgarian Study

    Article • Antibodies, March 2022, MDPI AG

    Dr Tsvetelina V Velikova

  138. COVID-19 Delta Wave Caused Early Overburden of Hospital Capacity in the Bulgarian Healthcare System in 2021

    Article • Healthcare, March 2022, MDPI AG

    Dr Tsvetelina V Velikova

  139. Immune titers of protection against severe acute respiratory syndrome coronavirus 2: are we there yet?

    Article • Exploration of Immunology, February 2022, Open Exploration Publishing

    Dr Tsvetelina V Velikova

  140. Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination

    Article • Rheumatology International, January 2022, Springer Science + Business Media

    Assoc. prof. Irena Ivanova, Dr Tsvetelina V Velikova

  141. Alterations of gut bacteria Akkermansia muciniphila and Faecalibacterium prausnitzii in late post-transplant period after liver transplantation

    Article • Iberoamerican Journal of Medicine, January 2022, Iberoamerican Journal of Medicine

    Dr Tsvetelina V Velikova

  142. Omentin-1 and diabetic foot

    Article • The International Journal of Lower Extremity Wounds, January 2022, SAGE Publications

    Dr Tsvetelina V Velikova

  143. Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome

    Article • Archives of Endocrinology and Metabolism, January 2022, Archives of Endocrinology and Metabolism

    Dr Tsvetelina V Velikova

  144. Estimating COVID Case Fatality Rate in Bulgaria for 2020–2021

    Article • January 2022, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  145. Atopic Status in Children with Asthma and Respiratory Allergies—Comparative Analysis of Total IgE, ImmunoCAP Phadiatop/fx5 and Euroimmun Pediatric Immunoblot

    Article • Sinusitis, December 2021, MDPI AG

    Emilia Krassimirova Naseva, Dr Tsvetelina V Velikova

  146. Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19

    Article • World Journal of Hepatology, December 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  147. Markers of Endothelial Inflammation and Repair in a Group of Patients with ANCA-associated Vasculitis

    Article • December 2021, Prof. Marin Drinov Academic Publishing House

    Dr Tsvetelina V Velikova

  148. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol

    Article • Rheumatology International, November 2021, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  149. Genetic variation of TGF-ΒR2 as a protective genotype for the development of colorectal cancer in men

    Article • World Journal of Gastrointestinal Oncology, November 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  150. DYNAMICS OF CHILDHOOD RESPIRATORY INFECTIONS DURING THE COVID-19 PANDEMIC: THE EFFECT OF QUARANTINE АND BEYOND

    Article • Central Asian Journal of Medical Hypotheses and Ethics, October 2021, South Kazakhstan Medical Academy

    Dr Tsvetelina V Velikova

  151. MY LIFE AS A RESEARCHER AND EDUCATOR

    Article • Central Asian Journal of Medical Hypotheses and Ethics, October 2021, South Kazakhstan Medical Academy

    Dr Tsvetelina V Velikova

  152. Liver Involvement in Children with COVID-19 and Multisystem Inflammatory Syndrome: A Single-Center Bulgarian Observational Study

    Article • Microorganisms, September 2021, MDPI AG

    Dr Tsvetelina V Velikova

  153. Surgical complications in COVID-19 patients in the setting of moderate to severe disease

    Article • World Journal of Gastrointestinal Surgery, August 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  154. Gastrointestinal mucosal immunity and COVID-19

    Article • World Journal of Gastroenterology, August 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  155. Foremost Concepts in Mechanisms of De Novo Post-Liver Transplantation Malignancy

    Article • Gastroenterology Insights, June 2021, MDPI AG

    Dr Tsvetelina V Velikova

  156. Neopterin in the Evolution from Obesity to Prediabetes and Newly Diagnosed Type 2 Diabetes

    Article • Metabolic Syndrome and Related Disorders, May 2021, Mary Ann Liebert Inc

    Dr Tsvetelina V Velikova

  157. INFECTION-ACQUIRED VERSUS VACCINE-INDUCED IMMUNITY AGAINST COVID-19

    Article • Central Asian Journal of Medical Hypotheses and Ethics, April 2021, South Kazakhstan Medical Academy

    Dr Tsvetelina V Velikova

  158. Biomarkers in Irritable Bowel Syndrome: Biological Rationale and Diagnostic Value

    Article • Digestive Diseases, March 2021, Karger Publishers

    Dr Tsvetelina V Velikova

  159. Immunological and microRNA Features of Allergic Rhinitis in the Context of United Airway Disease

    Article • Sinusitis, February 2021, MDPI AG

    Dr Tsvetelina V Velikova

  160. Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure

    Article • International Journal of Molecular Sciences, February 2021, MDPI AG

    Dr Tsvetelina V Velikova

  161. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis

    Article • Rheumatology International, January 2021, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  162. Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control

    Article • BioMed Research International, January 2021, Wiley

    Dr Tsvetelina V Velikova

  163. Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?

    Article • Gastroenterology Insights, December 2020, MDPI AG

    Dr Tsvetelina V Velikova

  164. Increased PD-L1 expression in high-grade bladder cancer with squamous cell differentiation in Bulgarian and French patients' samples

    Article • Annals of Diagnostic Pathology, December 2020, Elsevier

    Dr Tsvetelina V Velikova

  165. What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis?

    Article • World Journal of Gastroenterology, November 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  166. Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes

    Article • Metabolic Syndrome and Related Disorders, November 2020, Mary Ann Liebert Inc

    Dr Tsvetelina V Velikova

  167. Left Ventricular Function Assessed by Myocardial Deformation and Torsion in Chronic Hemodialysis Patients

    Article • October 2020, Prof. Marin Drinov Academic Publishing House

    Dr Tsvetelina V Velikova

  168. A review on the evolution of immunotherapy in bladder carcinoma

    Article • Iberoamerican Journal of Medicine, October 2020, Iberoamerican Journal of Medicine

    Dr Tsvetelina V Velikova

  169. Relationship between circulating netrin-1 levels, obesity, prediabetes and newly diagnosed type 2 diabetes

    Article • Archives of Physiology and Biochemistry, July 2020, Taylor & Francis

    Dr Tsvetelina V Velikova

  170. Identification of Specific IgE Antibodies and Asthma Control Interaction and Association Using Cluster Analysis in a Bulgarian Asthmatic Children Cohort

    Article • Antibodies, July 2020, MDPI AG

    Dr Tsvetelina V Velikova

  171. Chemical Metabolism of Xenobiotics by Gut Microbiota

    Article • Current Drug Metabolism, June 2020, Bentham Science Publishers

    Dr Tsvetelina V Velikova

  172. Lactobacilli Supplemented with Larch Arabinogalactan and Colostrum Stimulates an Immune Response towards Peripheral NK Activation and Gut Tolerance

    Article • Nutrients, June 2020, MDPI AG

    Dr Tsvetelina V Velikova

  173. AB0020 CORRELATION BETWEEN SERUM AND SYNOVIAL CONCENTRATION OF IL-17A AND MIRNA EXPRESSION IN RHEUMATOID ARTHRITIS PATIENTS

    Article • Annals of the Rheumatic Diseases, June 2020, Elsevier

    Dr Tsvetelina V Velikova

  174. Impact of testosterone treatment on circulating irisin in men with late-onset hypogonadism and metabolic syndrome

    Article • The Aging Male, May 2020, Taylor & Francis

    Dr Tsvetelina V Velikova

  175. Retraction notice to “Alterations in cytokine gene expression profile in colon mucosa of inflammatory bowel disease patients on different therapeutic regimens” [Cytokine 92 (2017) 12–19]

    Article • Cytokine, May 2020, Elsevier

    Dr Tsvetelina V Velikova

  176. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer

    Article • World Journal of Gastroenterology, April 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  177. Epidemiological and Morphological Characteristics of Urothelial Bladder Cancer in a Bulgarian and a French Sample of Patients

    Article • American International Journal of Multidisciplinary Scientific Research, March 2020, Centre for Research on Islamic Banking and Finance and Business

    Dr Tsvetelina V Velikova

  178. Challenges and updates in the management of eosinophilic esophagitis

    Article • Gastroenterology Review, January 2020, Termedia Sp. z.o.o.

    Dr Tsvetelina V Velikova

  179. Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus

    Article • Clinical & Experimental Immunology, December 2019, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  180. Peroxiredoxin 4 levels in patients with PCOS and/or obesity

    Article • Journal of Gynecology Obstetrics and Human Reproduction, November 2019, Elsevier

    Dr Tsvetelina V Velikova

  181. The association between retinol-binding protein 4 and prediabetes in obese patients with nonalcoholic fatty liver disease

    Article • Archives of Physiology and Biochemistry, October 2019, Taylor & Francis

    Antoaneta Gateva, Dr Tsvetelina V Velikova , Vera Karamfilova

  182. Serum Periostin Levels in Patients with Moderate to Severe Persistent Bronchial Asthma

    Article • July 2019, Prof. Marin Drinov Academic Publishing House

    Dr Tsvetelina V Velikova

  183. Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma

    Article • Respiratory Medicine, July 2019, Elsevier

    Dr Tsvetelina V Velikova

  184. Trefoil Factor 3 is Highly Predictive of Complete Mucosal Healing Independently and in Combination with C-Reactive Protein in Patients with Ulcerative Colitis

    Article • Journal of Gastrointestinal and Liver Diseases, June 2019, Romanian Society of Gastroenterology and Heptatology

    Dr Tsvetelina V Velikova

  185. Celiac-Related Autoantibodies and IL-17A in Bulgarian Patients with Dermatitis Herpetiformis: A Cross-Sectional Study

    Article • Medicina, May 2019, MDPI AG

    Dr Tsvetelina V Velikova

  186. P100 Systemic and local IL-17A and miR-146A levels in rheumatoid arthritis patients

    Article • Annals of the Rheumatic Diseases, March 2019, Elsevier

    Dr Tsvetelina V Velikova

  187. P101 Systemic and local IL-17A and miR-155 levels in rheumatoid arthritis patients

    Article • Annals of the Rheumatic Diseases, March 2019, Elsevier

    Dr Tsvetelina V Velikova

  188. Effect of Diode Laser Treatment on the Level of IL‑6 in the Gingival Crevicular Fluid in Patients with Chronic Periodontitis

    Article • February 2019, Prof. Marin Drinov Academic Publishing House

    Dr Tsvetelina V Velikova

  189. P099 Patients with ulcerative colitis show increased Treg number in peripheral blood after 1 year of anti-TNF therapy

    Article • Journal of Crohn s and Colitis, January 2019, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  190. Higher levels of IL-18 in patients with prediabetes compared to obese normoglycaemic controls

    Article • Archives of Physiology and Biochemistry, January 2019, Taylor & Francis

    Antoaneta Gateva, Dr Tsvetelina V Velikova

  191. Higher levels of thioredoxin interacting protein (TXNIP) in patients with prediabetes compared to obese normoglycemic subjects

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, January 2019, Elsevier

    Dr Tsvetelina V Velikova

  192. Interactions of allergic rhinitis and bronchial asthma at mucosal immunology level

    Article • AIMS Allergy and Immunology, January 2019, American Institute of Mathematical Sciences (AIMS)

    Dr Tsvetelina V Velikova

  193. Serum levels of IL-5, IL-6 and IL-8 in moderate and severe asthma clusters

    Article • September 2018, European Respiratory Society (ERS)

    Dr Tsvetelina V Velikova

  194. Predictors of severe exacerbations in patients with moderate and severe asthma

    Article • September 2018, European Respiratory Society (ERS)

    Dr Tsvetelina V Velikova

  195. Th17 cells in Bulgarian children with chronic obstructive lung diseases

    Article • Allergologia et Immunopathologia, September 2018, Elsevier

    Dr Tsvetelina V Velikova

  196. Soluble CD14 is Associated with Disease Activity and Severity in Chronic Viral Hepatitis C and B

    Article • June 2018, Prof. Marin Drinov Academic Publishing House

    Dr Tsvetelina V Velikova

  197. AB0078 Systemic and local il-17a and mir-223 levels in rheumatoid arthritis patients

    Article • Annals of the Rheumatic Diseases, June 2018, Elsevier

    Dr Tsvetelina V Velikova

  198. MCP-1/CCL2 in a Bulgarian Cohort of Children with Bronchial Asthma and Cystic Fibrosis

    Article • April 2018, MDPI AG

    Dr Tsvetelina V Velikova

  199. Dynamics of Some Routine Immunological Parameters During Anti - TNF Therapy in Patients with Crohn’s Disease

    Article • Annals of Colorectal Research, March 2018, Kowsar Medical Institute

    Dr Tsvetelina V Velikova

  200. Serological Update on Celiac Disease Diagnostics in Adults

    Article • International Journal of Celiac Disease, March 2018, Science and Education Publishing Co., Ltd.

    Dr Tsvetelina V Velikova

  201. Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy

    Article • Acta Medica Bulgarica, March 2018, De Gruyter

    Dr Tsvetelina V Velikova

  202. Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes

    Article • Endocrine Connections, December 2017, Bioscientifica

    Dr Tsvetelina V Velikova

  203. Reduced soluble Toll-like receptors 2 in type 2 diabetes

    Article • Archives of Physiology and Biochemistry, November 2017, Taylor & Francis

    Emanuela Zaharieva, Dr Tsvetelina V Velikova

  204. Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study

    Article • Rheumatology International, November 2017, Springer Science + Business Media

    Dr Tsvetelina V Velikova

  205. 516 Dermatitis herpetiformis in Bulgaria: Report of 78 patients

    Article • Journal of Investigative Dermatology, October 2017, Elsevier

    Dr Tsvetelina V Velikova

  206. Serum levels of IL-6 in adult patients with moderate to severe asthma

    Article • September 2017, European Respiratory Society (ERS)

    Dr Tsvetelina V Velikova

  207. AB0170 Diminished peripheral t-cell activation along with marked th17 circulating profile in ssc

    Article • Annals of the Rheumatic Diseases, June 2017, Elsevier

    Dr Tsvetelina V Velikova

  208. Reduced level of soluble TLR2 in type 2 diabetes despite increased TLR2 monocyte expression

    Article • Endocrine Abstracts, May 2017, Bioscientifica

    Dr Tsvetelina V Velikova

  209. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens

    Article • Cytokine, April 2017, Elsevier

    Dr Tsvetelina V Velikova

  210. 03.04 Serum and synovial concentration of calprotectin in rheumatoid arthritis patients

    Article • March 2017, BMJ

    Dr Tsvetelina V Velikova

  211. 03.07 Serum and synovial concentration of il-17a in rheumatoid arthritis patients

    Article • March 2017, BMJ

    Dr Tsvetelina V Velikova

  212. Increased kallistatin levels in patients with obesity and prediabetes compared to normal glucose tolerance

    Article • Endocrine Research, February 2017, Taylor & Francis

    Dr Tsvetelina V Velikova

  213. Phenotypes Determined by Cluster Analysis in Moderate to Severe Bronchial Asthma

    Article • Folia Medica, January 2017, De Gruyter

    Vania Youroukova, Dr Tsvetelina V Velikova

  214. Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients

    Article • World Journal of Experimental Medicine, January 2017, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Tsvetelina V Velikova

  215. Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian Population

    Article • Journal of Diabetes Research, January 2017, Hindawi Publishing Corporation

    Dr Tsvetelina V Velikova , Emanuela Zaharieva

  216. Cytokines in Inflamed Mucosa of IBD Patients

    Article • October 2016, IntechOpen

    Dr Tsvetelina V Velikova

  217. Increased peroxiredoxin 4 levels in patients with prediabetes compared to normal glucose tolerance subjects

    Article • Clinical Endocrinology, July 2016, Wiley

    Dr Tsvetelina V Velikova , Antoaneta Gateva

  218. Myostatin and carbohydrate disturbances

    Article • Endocrine Research, June 2016, Taylor & Francis

    Dr Tsvetelina V Velikova

  219. AB0637 Markers of Endothelial Inflammation and Repair in a Group of Patients with Systemic Vasculitis

    Article • Annals of the Rheumatic Diseases, June 2015, Elsevier

    Dr Tsvetelina V Velikova

  220. P-178 YI Specific mRNA Expression Profile in Inflamed Colonic Mucosa Derived from Patients with Inflammatory Bowel Disease

    Article • Inflammatory Bowel Diseases, December 2014, Oxford University Press (OUP)

    Dr Tsvetelina V Velikova

  221. Cells Isolated from Human Glioblastoma Multiforme Express Progesterone-Induced Blocking Factor (PIBF)

    Article • Cellular and Molecular Neurobiology, January 2014, Springer Science + Business Media

    Emanuil Naydenov, Dr Tsvetelina V Velikova